Thomasville National Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
+91,822
New +$12.1M 0.64% 39
2025
Q4
$13.5M Buy
109,662
+2,417
+2% +$294K 0.83% 33
2025
Q3
$11.9M Buy
107,245
+1,750
+2% +$199K 0.75% 35
2025
Q2
$11.7M Sell
105,495
-1,644
-2% -$175K 0.8% 35
2025
Q1
$12M Sell
107,139
-89,340
-45% -$9.22M 0.88% 33
2024
Q4
$18.1M Buy
196,479
+4,327
+2% +$390K 1.3% 26
2024
Q3
$16.1M Buy
192,152
+12,951
+7% +$988K 1.19% 30
2024
Q2
$12.3M Buy
179,201
+11,102
+7% +$741K 0.98% 29
2024
Q1
$12.3M Buy
168,099
+12,026
+8% +$925K 1.01% 30
2023
Q4
$12.6M Buy
156,073
+3,511
+2% +$273K 1.12% 29
2023
Q3
$11.4M Buy
152,562
+3,018
+2% +$232K 1.12% 29
2023
Q2
$11.5M Buy
149,544
+4,750
+3% +$379K 1.1% 27
2023
Q1
$12M Buy
144,794
+43
+0% +$3.56K 1.24% 27
2022
Q4
$12.4M Sell
144,751
-5,720
-4% -$453K 1.43% 24
2022
Q3
$9.28M Buy
150,471
+6,321
+4% +$399K 1.11% 29
2022
Q2
$8.91M Buy
144,150
+5,478
+4% +$339K 0.98% 30
2022
Q1
$8.24M Buy
138,672
+6,508
+5% +$416K 0.8% 36
2021
Q4
$9.6M Buy
132,164
+8,344
+7% +$575K 0.92% 33
2021
Q3
$8.65M Buy
123,820
+7,081
+6% +$497K 0.9% 34
2021
Q2
$8.04M Sell
116,739
-28,761
-20% -$1.92M 0.85% 33
2021
Q1
$10.9M Buy
145,500
+47,384
+48% +$3.06M 2.03% 18
2020
Q4
$5.72M Sell
98,116
-44,768
-31% -$2.7M 0.75% 33
2020
Q3
$9.03M Sell
142,884
-1,411
-1% -$97.8K 1.36% 24
2020
Q2
$11.1M Buy
+144,295
New +$11.1M 1.72% 23
2018
Q4
Sell
-2,664
Closed -$206K 184
2018
Q3
$206K Sell
2,664
-190
-7% -$14.3K 0.03% 189
2018
Q2
$202K Buy
2,854
+80
+3% +$5.65K 0.03% 187
2018
Q1
$209K Buy
+2,774
New +$221K 0.04% 187
2017
Q4
Sell
-3,702
Closed -$300K 214
2017
Q3
$300K Sell
3,702
-866
-19% -$66.2K 0.05% 198
2017
Q2
$323K Sell
4,568
-58,663
-93% -$3.9M 0.06% 182
2017
Q1
$4.29M Buy
+63,231
New +$4.45M 0.85% 31
2016
Q3
$203K Sell
2,572
-58,357
-96% -$4.74M 0.12% 75
2016
Q2
$5.08M Buy
60,929
+3,624
+6% +$322K 1.34% 24
2016
Q1
$5.26M Buy
57,305
+2,780
+5% +$251K 1.59% 24
2015
Q4
$5.52M Buy
54,525
+1,040
+2% +$108K 1.95% 19
2015
Q3
$5.25M Buy
53,485
+1,101
+2% +$122K 1.92% 19
2015
Q2
$6.13M Sell
52,384
-618
-1% -$67.5K 2.12% 12
2015
Q1
$5.2M Buy
53,002
+1,152
+2% +$117K 1.78% 22
2014
Q4
$4.89M Buy
51,850
+6,480
+14% +$670K 1.75% 24
2014
Q3
$4.83M Buy
45,370
+1,885
+4% +$185K 1.85% 20
2014
Q2
$3.6M Buy
43,485
+2,034
+5% +$158K 1.32% 32
2014
Q1
$2.94M Sell
41,451
-212
-0.5% -$16.6K 1.21% 33
2013
Q4
$3.13M Buy
41,663
+2,566
+7% +$179K 1.38% 32
2013
Q3
$2.46M Buy
+39,097
New +$2.34M 1.28% 31

Other funds holding GILD

Thomasville National Bank's GILD Position: Q2 2026 in Review

Thomasville National Bank opened a new position in Gilead Sciences (GILD) in Q2 2026: 91,822 shares worth $11.6M. The stake represents 0.64% of the portfolio and ranks #39 among its holdings. This is a return to the name: Thomasville National Bank previously reported a position in GILD as recently as Q4 2025.

Thomasville National Bank first reported a position in GILD in Q3 2013 and has held it in 43 quarters since. The position peaked at $18.1M in Q4 2024. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Thomasville National Bank held 91,822 shares of Gilead Sciences worth $11.6M as of Q2 2026.
  • Gilead Sciences was a new Thomasville National Bank position in Q2 2026.
  • Gilead Sciences made up 0.64% of Thomasville National Bank's portfolio in Q2 2026, its #39 holding.
  • Thomasville National Bank first reported a position in Gilead Sciences in Q3 2013 and has held it in 43 quarters since.
  • Thomasville National Bank's Gilead Sciences position peaked at $18.1M in Q4 2024.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Thomasville National Bank's 13F filing for Q2 2026, filed 20 Jul 2026.